US2006191547A1PendingUtilityA1
Modifying nicotine and nitrosamine levels in tobacco
Individually held — no corporate assignee on recordPriority: Jun 8, 2001Filed: May 1, 2006Published: Aug 31, 2006
Est. expiryJun 8, 2021(expired)· nominal 20-yr term from priority
Inventors:Mark Conkling
A61P 35/00C07K 14/415A24B 15/245A24B 15/18A24B 15/243C12N 15/8243C12N 9/1077A24B 15/20A24B 15/10A61P 25/34
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention generally relates to tobacco and tobacco products having a reduced amount of nicotine and/or tobacco specific nitrosamines (TSNA). More specifically, several ways to make tobacco plants that have reduced nicotine and TSNA levels have been discovered. Embodiments include tobacco harvested from said tobacco plants, cured tobacco from said tobacco plants, tobacco products made with said cured tobacco and methods of making these compositions.
Claims
exact text as granted — not AI-modified1 . A smoking cessation program comprising a cured tobacco that comprises a genetic modification, a reduced amount of nicotine, and a collective content of N′-nitrosonornicotine (NNN), N′-nitrosoanatabine (NAT), N′-nitrosoanabasine (NAB), 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) of between about 0-5.0 μg/g in the mainstream smoke generated therefrom.
Join the waitlist — get patent alerts
Track US2006191547A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.